CAMP4 THERAPEUTICS Net Worth
CAMP4 THERAPEUTICS Net Worth Breakdown | CAMP |
CAMP4 THERAPEUTICS Net Worth Analysis
CAMP4 THERAPEUTICS's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including CAMP4 THERAPEUTICS's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of CAMP4 THERAPEUTICS's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform CAMP4 THERAPEUTICS's net worth analysis. One common approach is to calculate CAMP4 THERAPEUTICS's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares CAMP4 THERAPEUTICS's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing CAMP4 THERAPEUTICS's net worth. This approach calculates the present value of CAMP4 THERAPEUTICS's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of CAMP4 THERAPEUTICS's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate CAMP4 THERAPEUTICS's net worth. This involves comparing CAMP4 THERAPEUTICS's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into CAMP4 THERAPEUTICS's net worth relative to its peers.
Enterprise Value |
|
To determine if CAMP4 THERAPEUTICS is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding CAMP4 THERAPEUTICS's net worth research are outlined below:
CAMP4 THERAPEUTICS generated a negative expected return over the last 90 days | |
CAMP4 THERAPEUTICS has high historical volatility and very poor performance | |
CAMP4 THERAPEUTICS has high likelihood to experience some financial distress in the next 2 years | |
The company reported the previous year's revenue of 186.23 M. Net Loss for the year was (49.29 M) with profit before overhead, payroll, taxes, and interest of 0. | |
CAMP4 THERAPEUTICS PORATION currently holds about 47.72 M in cash with (44.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29. | |
CAMP4 THERAPEUTICS has a frail financial position based on the latest SEC disclosures | |
Latest headline from prnewswire.com: KLYMIT DRIFT CAMP PILLOW SELECTED AS A WINNER IN GOOD HOUSEKEEPINGS 2025 FAMILY TRAVEL AWARDS |
CAMP4 THERAPEUTICS Quarterly Good Will |
|
CAMP4 THERAPEUTICS uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in CAMP4 THERAPEUTICS PORATION. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to CAMP4 THERAPEUTICS's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
25th of April 2024 Upcoming Quarterly Report | View | |
8th of July 2024 Next Financial Report | View | |
29th of February 2024 Next Fiscal Quarter End | View | |
25th of April 2024 Next Fiscal Year End | View | |
30th of November 2023 Last Quarter Report | View | |
28th of February 2023 Last Financial Announcement | View |
Follow CAMP4 THERAPEUTICS's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 660.34 K.Market Cap |
|
Project CAMP4 THERAPEUTICS's profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.23) | (0.22) | |
Return On Capital Employed | (0.04) | (0.05) | |
Return On Assets | (0.16) | (0.15) | |
Return On Equity | (0.57) | (0.54) |
When accessing CAMP4 THERAPEUTICS's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures CAMP4 THERAPEUTICS's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of CAMP4 THERAPEUTICS's profitability and make more informed investment decisions.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CAMP4 THERAPEUTICS insiders, such as employees or executives, is commonly permitted as long as it does not rely on CAMP4 THERAPEUTICS's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CAMP4 THERAPEUTICS insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Clark Jeffrey P. over a month ago Disposition of 1448 shares by Clark Jeffrey P. of CAMP4 THERAPEUTICS subject to Rule 16b-3 | ||
Nathan Lowstuter over a month ago Disposition of 10000 shares by Nathan Lowstuter of CAMP4 THERAPEUTICS subject to Rule 16b-3 | ||
Nathan Lowstuter over three months ago Disposition of 15 shares by Nathan Lowstuter of CalAmp Corp at 0.8766 subject to Rule 16b-3 | ||
Jikun Kim over six months ago Disposition of 487 shares by Jikun Kim of CalAmp Corp at 3.68 subject to Rule 16b-3 | ||
Cummins Wes over six months ago Acquisition by Cummins Wes of 25000 shares of CalAmp Corp at 3.9516 subject to Rule 16b-3 | ||
Jason Cohenour over six months ago Disposition of 7824 shares by Jason Cohenour of CalAmp Corp subject to Rule 16b-3 | ||
Wolberg Kirsten O over a year ago Acquisition by Wolberg Kirsten O of 46667 shares of CalAmp Corp subject to Rule 16b-3 | ||
Xiaolian Zhang over a year ago Payment of 412 shares by Xiaolian Zhang of CalAmp Corp subject to Rule 16b-3 |
CAMP4 THERAPEUTICS Corporate Filings
8K | 1st of August 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
18th of July 2024 Other Reports | ViewVerify | |
28th of June 2024 Other Reports | ViewVerify | |
F4 | 6th of June 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
CAMP4 THERAPEUTICS Earnings per Share Projection vs Actual
CAMP4 THERAPEUTICS Corporate Management
Kelly Gold | Chief Officer | Profile | |
John Partain | Interim Experience | Profile | |
Erik Schulz | Interim Officer | Profile | |
Christian Horne | Interim Sales | Profile | |
Brett Jackson | Senior Logistics | Profile | |
Mark Gaydos | Chief Officer | Profile |
Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.